PRESS RELEASE CRYOSTEM invests the field of HSCT research • CRYOSTEM attends the 43rd Annual Meeting of EBMT (Marseille, March 26 -­‐ 29, 2017) and will welcome professional on booth 40, • CRYOSTEM supports the Basic Science Award for Physicians that will be presented on March 26 at 7.45 pm (CET). Marseille, march 23, 2017 : CRYOSTEM, a national cohort dedicated to Hematopoietic Stem Cell Transplantation (HSCT) and its complications, attends the 43rd Annual Meeting of EBMT (European Society for Blood and Marrow Transplantation, https://www.ebmt.org/) that will be held in the "Parc Chanot -­‐ Palais des Congrès of Marseille" from March 26 to 29, 2017. This international event gathering bone marrow transplant top experts (academic and clinical teams, patient associations and industrial entrepreneurs) but also patients and marrow donors, will be the opportunity for CRYOSTEM to share with its visitors the action carried out through its national network of transplant units and biological resources centers since its creation in 2011. The CRYOSTEM team will present the conditions of access to its collection, unique in Europe, of over 148,000 biological samples of donor-­‐recipient pairs before and after transplantation, dedicated to basic and applied research projects. Initially focused on the single disease of Graft-­‐versus-­‐Host Disease (GvHD), the scope was further extended in November 2016 to all the complications of HSCT. CRYOSTEM will also introduce "HTC Project", its new research program without borders, open to all, which already foster 4 innovative projects in the field of HSCT and its complications. Finally, CRYOSTEM will present the Basic Science Award for Physicians selected from the top-­‐
scored abstracts by the EBMT Board of Association and Scientific Committee. The award ceremony is scheduled on March 26 at 7.45 pm (CET) in the auditorium. Make sure to visit CRYOSTEM on booth 40 ! About Cryostem: Launched within the framework of Investments for the Future by the National Research Agency (ANR), at the heart of the French Government’s Plan Cancer and supported by the National Cancer Institute (INCa), the CRYOSTEM’s project was initiated in 2011 under the auspices of the Francophone Society of Marrow Transplantations and Cellular Therapy (SFGM-­‐TC) to accelerate research in the area of complications of Hematopoietic Stem Cell Transplantation (HSCT), previously called bone marrow transplantation. More information : http://www.cryostem.org / http://www.htcproject.org LinkedIn : https://www.linkedin.com/company/cryostem Twitter: @cryostem_FR PRESS CONTACT Marie PUVIEUX (France) +33 (0)6 10 54 36 72 Jean Medhi GRANGEON (UK/US) +33 (0)6 62 22 00 24 presse@atcg-­‐partners.com 2